TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
27.71
-0.37 (-1.32%)
At close: Aug 18, 2025, 3:59 PM
27.79
0.27%
After-hours: Aug 18, 2025, 07:20 PM EDT
TG Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 141.15M | 120.86M | 108.19M | 83.88M | 73.47M | 63.47M | 43.97M | 165.81M | 16.07M | 7.8M | 80K | 94K | 594K | 2.02M | 2.32M | 2.03M | 1.54M | 793K |
Cost of Revenue | 18.94M | 15.54M | 15.4M | 9.34M | 8.3M | 5.52M | 7.95M | 3.51M | 1.91M | 857K | 3K | 2K | 23K | 237K | 210K | 292K | 148K | 139K |
Gross Profit | 122.21M | 105.31M | 92.79M | 74.54M | 65.16M | 57.95M | 36.02M | 162.31M | 14.16M | 6.95M | 77K | 92K | 571K | 1.78M | 2.11M | 1.74M | 1.4M | 654K |
Operating Income | 34.84M | 8.62M | 29.95M | 12.43M | 8.82M | -9.27M | -12.48M | 114.78M | -44.67M | -36.99M | -52.06M | -34.96M | -38.94M | -66.87M | -92.95M | -85.13M | -77.49M | -89.2M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 30.92M | 5.47M | 25.45M | 4.27M | 6.55M | -10.68M | -14.03M | 113.93M | -47.61M | -39.23M | -52.99M | -35.82M | -40.51M | -69.01M | -93.34M | -85.64M | -78.5M | -90.63M |
Net Income | 28.19M | 5.06M | 23.33M | 3.88M | 6.88M | -10.71M | -14.42M | 113.93M | -47.61M | -38.63M | -52.99M | -36.67M | -42.08M | -71.15M | -93.34M | -85.64M | -78.5M | -90.63M |
Selling & General & Admin | 55.59M | 50.33M | 38.96M | 41.97M | 38.72M | 34.5M | 31.06M | 26.5M | 36.38M | 29.65M | 22.5M | 17.5M | 14.97M | 22.5M | 37.4M | 34.9M | 41.03M | 34.27M |
Research & Development | 31.78M | 46.36M | 23.87M | 20.14M | 17.56M | 32.72M | 17.45M | 11.84M | 22.46M | 14.29M | 29.64M | 17.55M | 24.55M | 46.15M | 57.66M | 51.97M | 37.85M | 55.58M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.18M | n/a | n/a | n/a | n/a | n/a | 523K | 688K | 529K | 618K | 472K |
Operating Expenses | 87.37M | 96.69M | 62.84M | 62.1M | 56.35M | 67.22M | 48.51M | 47.52M | 58.84M | 43.94M | 52.14M | 35.05M | 39.51M | 68.65M | 95.06M | 86.87M | 78.89M | 89.86M |
Interest Expense | 6.72M | 6.76M | 7.06M | 10.83M | 3.98M | 2.29M | 2.43M | 3.71M | 3.63M | 2.84M | 2.86M | 1.65M | 3.02M | 2.66M | 1.08M | 1.04M | 1.62M | 1.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -72K | -82K | -2.94M | -9.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 106.31M | 112.23M | 78.24M | 71.44M | 64.65M | 72.74M | 56.46M | 51.03M | 60.75M | 44.8M | 52.14M | 35.06M | 39.53M | 68.89M | 95.27M | 87.16M | 79.04M | 90M |
Income Tax Expense | 2.73M | 408K | 2.12M | 388K | -328K | 29K | 390K | -126K | n/a | -604K | n/a | 855K | 1.57M | 2.14M | 391K | 509K | 1.01M | n/a |
Shares Outstanding (Basic) | 146.74M | 146.68M | 145.32M | 145.1M | 144.73M | 146.21M | 143.09M | 142.87M | 141.5M | 140.31M | 137.11M | 135.33M | 134.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
Shares Outstanding (Diluted) | 162.56M | 162.77M | 160.24M | 160.71M | 159.42M | 146.21M | 143.09M | 155.87M | 141.5M | 140.31M | 137.11M | 135.33M | 134.78M | 134.4M | 132.56M | 132.35M | 132.07M | 131.9M |
EPS (Basic) | 0.19 | 0.03 | 0.16 | 0.03 | 0.05 | -0.07 | -0.1 | 0.80 | -0.34 | -0.28 | -0.39 | -0.27 | -0.31 | -0.53 | -0.7 | -0.65 | -0.59 | -0.69 |
EPS (Diluted) | 0.17 | 0.03 | 0.15 | 0.02 | 0.04 | -0.07 | -0.1 | 0.73 | -0.34 | -0.28 | -0.39 | -0.27 | -0.31 | -0.53 | -0.7 | -0.65 | -0.59 | -0.69 |
EBITDA | 37.64M | 12.28M | 32.07M | 15.1M | 10.6M | -8.31M | -11.5M | 117.77M | -43.9M | -36.27M | -51.99M | -34.04M | -37.36M | -66.22M | -92.13M | -84.47M | -76.75M | -88.62M |
EBIT | 37.64M | 12.22M | 32.01M | 15.1M | 10.53M | -8.39M | -11.6M | 117.64M | -43.98M | -36.39M | -50.13M | -34.17M | -37.49M | -66.35M | -92.26M | -84.6M | -76.87M | -88.73M |
Depreciation & Amortization | n/a | 56K | 62K | 64K | 72K | 82K | 91K | 126K | 85K | 121K | 126K | 129K | 131K | 129K | 133K | 129K | 120K | 112K |